Home › Merck Sues Actavis Unit Over Patent for Generic NuvaRing
 

Keywords :   


Merck Sues Actavis Unit Over Patent for Generic NuvaRing

2013-12-25 00:26:03| Biotech - Topix.net

Merck & Co. sued Actavis Plc's Warner Chilcott unit seeking to block sales of a generic version of NuvaRing, a contraceptive with estimated annual sales of more than $664 million.

Tags: unit patent generic merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 18
03.07Hurricane Beryl Wind Speed Probabilities Number 18
03.07Hurricane Beryl Public Advisory Number 18
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 18
03.07Hurricane Beryl Graphics
03.07Atlantic Tropical Weather Outlook
More »